Follow The Filings

NUVB Nuvation Bio

Nuvation Bio earnings company data as of 7:04 PM ET 11/17

  • 0 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS -0.10 -0.12 Miss
Rev $34.4M — —

Insider trades

Open-market buys and sales by NUVB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NUVB insider trades
  • $118K bought by 1 insider
  • $1.3M sold by 1 insider outside a trading plan
  • $3.5M sold by 5 insiders under 10b5-1 plans
  1. Gary Hattersley Chief Scientific Officer
    Planned sale
    $709K 100,000 shares at $7.09 100% of stake
    Traded Aug 19 Filed Aug 21
  2. Philippe Sauvage CFO
    Planned sale
    $286K 47,668 shares at $6.01 79% of stake
    Traded Jun 23 Filed Jun 24
  3. Stacy Markel Chief People Officer
    Planned sale
    $753K 125,000 shares at $6.03 79% of stake
    Traded Jun 23 Filed Jun 24
  4. Kerry Wentworth Chief Regulatory Officer
    Planned sale
    $379K 63,000 shares at $6.02 54% of stake
    Traded Jun 23 Filed Jun 24
  5. Robert Mashal Director
    Buy
    $118K 25,000 shares at $4.73 +13% to stake
    Traded Jun 9 Filed Jun 11
  6. Dongfang Liu Chief Medical Officer
    Planned sale
    $251K 50,000 shares at $5.02 74% of stake
    Traded Apr 17 Filed Apr 21
  7. Kerry Wentworth Chief Regulatory Officer
    Planned sale
    $184K 36,750 shares at $5.01 41% of stake
    Traded Apr 17 Filed Apr 21
  8. Kerry Wentworth Chief Regulatory Officer
    Planned sale
    $904K 200,000 shares at $4.52 79% of stake
    Traded Apr 6 Filed Apr 8
  9. Dongfang Liu Chief Medical Officer
    Sale
    $1.2M 150,000 shares at $7.82 89% of stake
    Traded Dec 1, 2025 Filed Dec 3, 2025
  10. Dongfang Liu Chief Medical Officer
    Sale
    $155K 20,000 shares at $7.75 53% of stake
    Traded Nov 25–26 Filed Nov 26, 2025
  11. Dongfang Liu Chief Medical Officer
    Sale
    $140K 20,000 shares at $7.00 53% of stake
    Traded Nov 20, 2025 Filed Nov 24, 2025
  12. Gary Hattersley Chief Scientific Officer
    Sale
    $2.7M 369,051 shares at $7.23 100% of stake
    Traded Nov 20, 2025 Filed Nov 24, 2025
  13. David C. Hanley Chief Technical Operations
    Sale
    $1.4M 200,000 shares at $7.14 89% of stake
    Traded Nov 19, 2025 Filed Nov 21, 2025
  14. Dongfang Liu Chief Medical Officer
    Sale
    $148K 30,000 shares at $4.93 63% of stake
    Traded Nov 17–19 Filed Nov 19, 2025
  15. Gary Hattersley Chief Scientific Officer
    Planned sale
    $502K 100,000 shares at $5.02 100% of stake
    Traded Oct 27, 2025 Filed Oct 29, 2025

Also filed in the last 12 months, not counted as buying or selling: 14 option exercises and 1 stock grant.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
10-Q
8-K 2.02,9.01
10-Q
8-K 2.02,9.01
8-K 2.03,8.01,9.01
8-K 1.01,1.02,2.03,8.01,9.01
424B5
424B5
8-K 5.07
10-Q
8-K 2.02,9.01
DEFA14A
DEF 14A
10-K

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf